Outcomes of p53 activation - spoilt for choice
Author:
- 15 December 2006
- journal article
- review article
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 119 (24) , 5015-5020
Abstract
The p53 tumour suppressor protein can efficiently inhibit tumour development. This activity reflects its ability to induce a number of different responses, including cell cycle arrest and apoptosis. Recent studies have revealed some interesting insights into how the choice of response to p53 is regulated, highlighting a correlation between the activation of cell cycle arrest and survival with the ability of p53 to reduce oxidative stress and protect cells from genotoxic damage. Understanding the molecular mechanisms that determine which response is selected may allow us to modulate these pathways so that therapeutic reactivation of p53 favours apoptotic cell death in tumour cells, but a reversible - and therefore far less toxic - induction of cell cycle arrest in normal cells.Keywords
This publication has 51 references indexed in Scilit:
- Acetylation of Mouse p53 at Lysine 317 Negatively Regulates p53 Apoptotic Activities after DNA DamageMolecular and Cellular Biology, 2006
- TIGAR, a p53-Inducible Regulator of Glycolysis and ApoptosisCell, 2006
- Repression of the Antiapoptotic Molecule Galectin-3 by Homeodomain-Interacting Protein Kinase 2-Activated p53 Is Required for p53-Induced ApoptosisMolecular and Cellular Biology, 2006
- Ser18 and 23 phosphorylation is required for p53‐dependent apoptosis and tumor suppressionThe EMBO Journal, 2006
- Regeneration of Peroxiredoxins by p53-Regulated Sestrins, Homologs of Bacterial AhpDScience, 2004
- ASPP1 and ASPP2: Common Activators of p53 Family MembersMolecular and Cellular Biology, 2004
- Unbiased Mapping of Transcription Factor Binding Sites along Human Chromosomes 21 and 22 Points to Widespread Regulation of Noncoding RNAsCell, 2004
- iASPP oncoprotein is a key inhibitor of p53 conserved from worm to humanNature Genetics, 2003
- Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activityNature Genetics, 2002
- Transcription Factor E2F-1 Is Upregulated in Response to DNA Damage in a Manner Analogous to That of p53Molecular and Cellular Biology, 1999